<DOC>
	<DOCNO>NCT01742000</DOCNO>
	<brief_summary>The purpose study investigate anti-atherosclerotic action natural drug Karinat base phytoestrogen-rich botanical postmenopausal woman .</brief_summary>
	<brief_title>Study Anti-atherosclerotic Activity Karinat Postmenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Beta Carotene</mesh_term>
	<criteria>Women least 5 year menopause Maximum intimamedia thickness common carotid artery 0,80 mm ( ultrasonographic Bmode examination ) The absence climacteric syndrome ( le 3 point BlattKupperman scale ) The absence chronic disease demand permanent drug administration ( 2 month per year ) The absence hypolipidemic therapy hormone replacement therapy 6 month inclusion Administration lipidlowering drug , and/or hormone replacement therapy , and/or phytoestrogens 6 month inclusion Continuous administration sulfonylurea derivative , and/or betablockers , and/or calcium antagonist ( 2 month per year ) Personal history diagnostic following disease : 1 . Personal history stroke , coronary heart disease , acute myocardial infarction transient ischemic attack 2 . Pulmonary thromboembolism 3 . Chronic heart failure IIaIII 4 . Uncontrolled arterial hypertension ( systolic blood pressure &gt; 145 mmHg , diastolic blood pressure &gt; 95 mmHg hypotensive therapy ) 5 . Malignancy 6 . Chronic renal failure IIIII 7 . Chronic hepatic failure IIIII 8 . Liver cirrhosis 9 . Individual intolerance Karinat major side effect</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>postmenopause</keyword>
	<keyword>phytoestrogen</keyword>
	<keyword>atherosclerosis</keyword>
	<keyword>intima-media thickness</keyword>
</DOC>